Alternatives to animal testing: Current status and future perspectives

Archives of Toxicology

Volumn 85, Issue 8, 2011, Pages 841-858

  Liebsch, Manfred ^a   Grune, Barbara ^a   Seiler, Andrea ^a   Butzke, Daniel ^a   Oelgeschläger, Michael ^a   Pirow, Ralph ^a   Adler, Sarah ^a   Riebeling, Christian ^a   Luch, Andreas ^a  

^a FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

Author keywords

3Rs; Alternatives to animal testing; Reduction; Refinement; Replacement; ZEBET

Indexed keywords

ACUTE TOXICITY; ANIMAL TESTING ALTERNATIVE; ANIMAL TESTING REDUCTION; ANIMAL TESTING REFINEMENT; ANIMAL TESTING REPLACEMENT; ANIMAL USE; CHRONIC TOXICITY; DEVICE SAFETY; DRUG RESEARCH; EMBRYONIC STEM CELL; EUROPE; EXPERIMENTAL ANIMAL; EXPERIMENTATION; HUMAN; LAW; NONHUMAN; PRIORITY JOURNAL; PRODUCT SAFETY; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; TOXICITY TESTING; TOXICOKINETICS; TOXICOLOGY;

ANIMAL TESTING ALTERNATIVES; ANIMALS; ANNIVERSARIES AND SPECIAL EVENTS; EUROPEAN UNION; HUMANS; INTERNATIONAL COOPERATION; MODELS, ANIMAL; RISK ASSESSMENT; TOXICITY TESTS;

ANIMALIA;

EID: 80052744919     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-011-0718-x     Document Type: Review

References (78)

1. S Adler G Bicker H Bigalke C Bishop J Blümel D Dressler J Fitzgerald F Gessler H Heuschen B Kegel A Luch C Milne A Pickett H Ratsch I Ruhdel D Sesardic M Stephens G Stiens PD Thornton R Thürmer M Vey H Spielmann B Grune M Liebsch 2010 The current scientific and legal status of alternative methods to the LD50 test for botulinum neurotoxin potency testing. The report and recommendations of a ZEBET expert meeting Altern Lab Anim 38 315 330 20822324 1:CAS:528:DC%2BC3cXhtF2rtLvI
2. ME Andersen D Krewski 2009 Toxicity testing in the 21st century: bringing the vision to life Toxicol Sci 107 324 330 19074763 10.1093/toxsci/kfn255 1:CAS:528:DC%2BD1MXhtVeht7g%3D
3. G Archer M Balls LH Bruner RD Curren JH Fentem HG Holzhutter M Liebsch DP Lovell JA Southee 1997 The validation of toxicological prediction models Altern Lab Anim 25 505 516 (Pubitemid 127520773)
4. M Balls 1997 Defined structural and performance criteria would facilitate the validation and acceptance of alternative test procedures Altern Lab Anim 25 483 484
5. M Balls B Blaauboer D Brusick J Frazier D Lamb M Pemberton C Reinhardt M Roberfroid H Rosenkranz B Schmid H Spielmann A-L Stammati E Walum 1990 Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures. Amden report Altern Lab Anim 18 313 337
6. M Balls BJ Blaauboer JH Fentem L Bruner RD Combes B Ekwall RJ Fielder A Guillouzo RW Lewis DP Lovell CA Reinhardt G Repetto D Sladowski H Spielmann F Zucco 1995 Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM workshop #5 Altern Lab Anim 23 129 147
7. RJ Box H Spielmann 2005 Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status Arch Toxicol 79 615 626 15940470 10.1007/s00204-005-0678-0 1:CAS:528:DC%2BD2MXht1SmtbrI (Pubitemid 41622189)
8. R Buesen E Genschow B Slawik A Visan H Spielmann A Luch A Seiler 2009 Embryonic stem cell test remastered: comparison between the validated EST and the new molecular FACS-EST for assessing developmental toxicity in vitro Toxicol Sci 108 389 400 19168572 10.1093/toxsci/kfp012 1:CAS:528:DC%2BD1MXktFWjtrc%3D
9. Bundesministerium fur Bildung und Forschung (2001) Hightech statt Tiere: Ersatz- und Ergänzungsmethoden zu Tierversuchen. http://www.bmbf.de/pub/ hightech-statt-tiere.pdf
10. L Cao X Liu EJ Lin C Wang EY Choi V Riban B Lin MJ During 2010 Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition Cell 142 52 64 20603014 10.1016/j.cell.2010.05.029 1:CAS:528:DC%2BC3cXpt1Cjt7c%3D
11. Carbone L (2004) What animals want; expertise and advocacy in laboratory animal welfare policy. Oxford University Press, New York
12. R Cecchelli V Berezowski S Lundquist M Culot M Renftel MP Dehouck L Fenart 2007 Modelling of the blood-brain barrier in drug discovery and development Nat Rev Drug Discov 6 650 661 17667956 10.1038/nrd2368 1:CAS:528:DC%2BD2sXotl2qtLc%3D (Pubitemid 47202487)
13. Commission of the European Communities (2007) Fifth report on the statistics on the number of animals used for experimental and other scientific purposes in the member states of the European Union, SEC(2007)1455. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:52007DC0675:EN:NOT
14. Council of Europe (2005) European convention for the protection of vertebrate animals used for experimental and other scientific purposes; CETS no.: 123. Council of Europe. http://conventions.coe.int/Treaty/Commun/ QueVoulezVous.asp?NT=123&CM=1&DF=20/10/2010&CL=ENG
15. Council of Europe (2011) Botulinum toxin type A for injection. Stationary Office Books, Strasbourg
16. E de Jong J Louisse M Verwei BJ Blaauboer JJ van de Sandt RA Woutersen IM Rietjens AH Piersma 2009 Relative developmental toxicity of glycol ether alkoxy acid metabolites in the embryonic stem cell test as compared with the in vivo potency of their parent compounds Toxicol Sci 110 117 124 19401353 10.1093/toxsci/kfp083
17. T Devolder K Reid V Rogiers S Webb D Wilkins 2008 A review of national public funding programmes in European countries ALTEX 25 233 242 18841318
18. Directive 2010/63/EU of the European parliament and of the council of 22 September 2010 on the protection of animals used for scientific purposes. Official Journal of the European Union. http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=OJ:L:2010:276:0033:0079:EN:PDF
19. Directorate General for the Environment (2010) Revision of directive 86/609/EEC on the protection of animals used for experimental and other scientific purposes. http://ec.europa.eu/environment/chemicals/lab-animals/ nextsteps-en.htm
20. DJ Dix KA Houck MT Martin AM Richard RW Setzer RJ Kavlock 2007 The ToxCast program for prioritizing toxicity testing of environmental chemicals Toxicol Sci 95 5 12 16963515 10.1093/toxsci/kfl103 1:CAS:528:DC%2BD28XhtlChtLjK (Pubitemid 44942773)
21. J Döhmer 2001 Modern drug development by molecular- and cell-biological methods ALTEX 18 9 12 11248843
22. C Emmerich 2009 Comparing first level patent data with value-added patent information: a case study in the pharmaceutical field World Pat Inf 31 117 122 10.1016/j.wpi.2008.06.003 1:CAS:528:DC%2BD1MXms1Srtb0%3D
23. TM human skin model. http://ecvam.jrc.it/publication/ESAC25-statement-SKINETHIC-correction-on181206- C.pdf
24. European Chemicals Agency (2009) New study inaccurate on the number of test animals for REACH. http://echa.europa.eu/doc/press/pr-09-11-animal-testing- 20090828.pdf
25. European Patent Office (2009) Business use of patent information. European Patent Office. http://www.epo.org/patents/patent-information/business. html
26. E Genschow H Spielmann G Scholz I Pohl A Seiler N Clemann S Bremer K Becker 2004 Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests Altern Lab Anim 32 209 244 15588166 1:CAS:528:DC%2BD2MXhsFSj (Pubitemid 39517737)
27. I Gerner K Schlegel JD Walker E Hulzebos 2004 Use of physicochemical property limits to develop rules for identifying chemical substances with no skin irritation or corrosion potential QSAR Comb Sci 23 726 733 10.1002/qsar.200430880 1:CAS:528:DC%2BD2cXhtVKls7nJ (Pubitemid 39578075)
28. C Giese CD Demmler R Ammer S Hartmann A Lubitz L Miller R Müller U Marx 2006 A human lymph node in vitro-challenges and progress Artif Organs 30 803 808 17026580 10.1111/j.1525-1594.2006.00303.x 1:CAS:528:DC%2BD28Xht12rtb%2FM (Pubitemid 44521372)
29. R Glaser JK Kiecolt-Glaser 2005 Stress-induced immune dysfunction: implications for health Nat Rev Immunol 5 243 251 15738954 10.1038/nri1571 1:CAS:528:DC%2BD2MXhslSju70%3D (Pubitemid 40364825)
30. 50) and to reduce testing in animals Altern Lab Anim 31 89 198 15612878 1:CAS:528:DC%2BD3sXktV2jtbk%3D (Pubitemid 36604738)
31. S Hansen A Henning A Naegel M Heisig G Wittum D Neumann KH Kostka J Zbytovska CM Lehr UF Schaefer 2008 In-silico model of skin penetration based on experimentally determined input parameters. Part I: experimental determination of partition and diffusion coefficients Eur J Pharm Biopharm 68 352 367 17587558 10.1016/j.ejpb.2007.05.012 1:CAS:528:DC%2BD1cXlsF2qsg%3D%3D
32. T Hartung I Aaberge S Berthold G Carlin E Charton S Coecke S Fennrich M Fischer M Gommer M Halder K Haslov M Jahnke T Montag-Lessing S Poole L Schechtman A Wendel G Werner-Felmayer 2001 Novel pyrogen tests based on the human fever reaction. The report and recommendations of ECVAM workshop #43. European Centre for the Validation of Alternative Methods Altern Lab Anim 29 99 123 11262757 1:STN:280:DC%2BD3M7msVajtA%3D%3D
33. C Helma 2006 Lazy structure-activity relationships (LAZAR) for the prediction of rodent carcinogenicity and Salmonella mutagenicity Mol Divers 10 147 158 16721629 10.1007/s11030-005-9001-5 1:CAS:528:DC%2BD28XntFyktrc%3D (Pubitemid 44092205)
34. T Höfer I Gerner U Gundert-Remy M Liebsch A Schulte H Spielmann R Vogel K Wettig 2004 Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation Arch Toxicol 78 549 564 15170526 10.1007/s00204-004-0577-9 (Pubitemid 39591625)
35. JA Hoffman BJ Merrill 2007 New and renewed perspectives on embryonic stem cell pluripotency Front Biosci 12 3321 3332 17485302 10.2741/2315 1:CAS:528:DC%2BD2sXms1Kmt7o%3D
36. HG Holzhütter 1997 A general measure of in vitro phototoxicity derived from pairs of dose-response curves and its use for predicting the in vivo phototoxicity of chemicals Altern Lab Anim 25 445 462
37. HG Holzhütter E Genschow W Diener E Schlede 2003 Dermal and inhalation acute toxic class methods: test procedures and biometric evaluations for the Globally harmonized classification system Arch Toxicol 77 243 254 12734637 (Pubitemid 36714069)
38. E Hulzebos JD Walker I Gerner K Schlegel 2005 Use of structural alerts to develop rules for identifying chemical substances with skin irritation or skin corrosion potential QSAR Comb Sci 24 332 342 10.1002/qsar.200430905 1:CAS:528:DC%2BD2MXktlSltrw%3D (Pubitemid 40637935)
39. ®: an in vitro test method for assessing dermal corrosivity potential of chemicals. The results of an independent peer review evaluation coordinated by the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and the National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM). National toxicology program. http://iccvam.niehs.nih.gov/docs/ reports/corprrep.pdf
40. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (2005a) ICH harmonised tripartite guideline: detection of toxicity to reproduction for medicinal products and toxicity to male fertility S5(R2). ICH Secretariat. http://www.ich.org/LOB/ media/MEDIA498.pdf
41. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (2005b) ICH harmonised tripartite guideline: validation of analytical procedures: text and methodology, Q2(R1). ICH Secretariat. http://www.ich.org/LOB/media/MEDIA417.pdf
42. H Kandarova M Liebsch H Spielmann E Genschow E Schmidt D Traue R Guest A Whittingham N Warren AO Gamer M Remmele T Kaufmann E Wittmer B De Wever M Rosdy 2006 Assessment of the human epidermis model SkinEthic RHE for in vitro skin corrosion testing of chemicals according to new OECD TG 431 Toxicol In Vitro 20 547 559 16455230 10.1016/j.tiv.2005.11.008 1:CAS:528:DC%2BD28XltlKhurk%3D (Pubitemid 43833269)
43. A Kretlow D Butzke ME Götz B Grune M Halder F Henkler M Liebsch R Nobiling M Oelgeschläger M Reifenberg B Schäfer A Seiler A Luch 2010 Implementation and enforcement of the 3Rs principle in the field of transgenic animals used for scientific purposes. Report and recommendations of the BfR expert workshop, May 18-20, 2009, Berlin, Germany ALTEX 27 117 123 21445538
44. D Krewski ME Andersen E Mantus L Zeise 2009 Toxicity testing in the 21st century: implications for human health risk assessment Risk Anal 29 474 479 19144067 10.1111/j.1539-6924.2008.01150.x
45. D Krewski D Acosta Jr M Andersen H Anderson JCI Bailar K Boekelheide R Brent G Charnley VG Cheung S Green Jr KT Kelsey NI Kerkvliet AA Li L McCray O Meyer RD Patterson W Pennie RA Scala GM Solomon M Stephens J Yager L Zeise 2010 Toxicity testing in the 21st century: a vision and a strategy J Toxicol Environ Health B Crit Rev 13 51 138 20574894 1:CAS:528:DC%2BC3cXnvFGksbY%3D
46. J Lamb 2007 The connectivity map: a new tool for biomedical research Nat Rev Cancer 7 54 60 17186018 10.1038/nrc2044 1:CAS:528:DC%2BD28XhtlCht7nF (Pubitemid 46020847)
47. K Linke J Schanz J Hansmann T Walles H Brunner H Mertsching 2007 Engineered liver-like tissue on a capillarized matrix for applied research Tissue Eng 13 2699 2707 17867928 10.1089/ten.2006.0388 1:CAS:528: DC%2BD2sXht1OrurnP (Pubitemid 350076745)
48. K Mclellan RE Das TA Ekong D Sesardic 1996 Therapeutic botulinum type A toxin: factors affecting potency Toxicon 34 975 985 8896190 10.1016/0041- 0101(96)00070-0 1:CAS:528:DyaK28XmtFKntro%3D (Pubitemid 26320008)
49. A Mess 2007 The Guinea pig placenta: model of placental growth dynamics Placenta 28 812 815 17382996 10.1016/j.placenta.2007.02.005 1:CAS:528: DC%2BD2sXotVGqt78%3D (Pubitemid 47074385)
50. E Motschall Y Falck-Ytter 2005 Searching the MEDLINE literature database through PubMed: a short guide Onkologie 28 517 522 16186693 10.1159/000087186 1:CAS:528:DC%2BD2MXhtVeitrfK (Pubitemid 41420849)
51. Organisation for Economic Co-Operation, Development 1996 OECD workshop on harmonisation of validation and acceptance Altern Lab Anim 24 7
52. Organisation for Economic Co-Operation, Development (2002) Final report of the OECD workshop on harmonization of validation and acceptance criteria for alternative toxicological test methods. OECD Publications Office, Paris
53. F Pampaloni EG Reynaud EH Stelzer 2007 The third dimension bridges the gap between cell culture and live tissue Nat Rev Mol Cell Biol 8 839 845 17684528 10.1038/nrm2236 1:CAS:528:DC%2BD2sXhtVKmt7vL (Pubitemid 47462131)
54. F Pampaloni EH Stelzer A Masotti 2009 Three-dimensional tissue models for drug discovery and toxicology Recent Pat Biotechnol 3 103 117 19519566 10.2174/187220809788700201 1:CAS:528:DC%2BD1MXotlWrtrk%3D
55. JA Paquette SW Kumpf RD Streck JJ Thomson RE Chapin DB Stedman 2008 Assessment of the embryonic stem cell test and application and use in the pharmaceutical industry Birth Defects Res B Dev Reprod Toxicol 83 104 111 18361453 10.1002/bdrb.20148 1:CAS:528:DC%2BD1cXlsl2kt7s%3D (Pubitemid 351631344)
56. AH Piersma 2006 Alternative methods for developmental toxicity testing Basic Clin Pharmacol Toxicol 98 427 431 16635099 10.1111/j.1742-7843.2006.pto- 373.x 1:CAS:528:DC%2BD28XltVyrur0%3D
57. Riebeling C, Pirow R, Becker K, Buesen R, Eikel D, Kaltenhäuser J, Meyer F, Nau H, Slawik B, Visan A, Volland J, Spielmann H, Luch A, Seiler A (2011) The embryonic stem cell test as tool to assess structure-dependent teratogenicity: the case of valproic acid. Toxicol Sci 120:360-370
58. C Rovida T Hartung 2009 Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals-a report by the transatlantic think tank for toxicology (t(4)) ALTEX 26 187 208 19907906
59. Russell WMS, Burch RL (1959) The principles of humane experimental technique. Methuen & Co. Ltd., London
60. UG Sauer T Wächter B Grune A Doms MR Alvers H Spielmann M Schroeder 2009 Go3R - semantic internet search engine for alternative methods to animal testing ALTEX 26 17 31 19326030
61. M Schäfer-Korting A Mahmoud BS Lombardi B Brüggener B Kleuser S Schreiber W Mehnert 2008 Reconstructed epidermis and full-thickness skin for absorption testing: influence of the vehicles used on steroid permeation Altern Lab Anim 36 441 452 18826333
62. A Seiler A Visan R Buesen E Genschow H Spielmann 2004 Improvement of an in vitro stem cell assay for developmental toxicity: the use of molecular endpoints in the embryonic stem cell test Reprod Toxicol 18 231 240 15019721 10.1016/j.reprotox.2003.10.015 1:CAS:528:DC%2BD2cXhvVygsrs%3D (Pubitemid 38333047)
63. AE Seiler R Buesen A Visan H Spielmann 2006 Use of murine embryonic stem cells in embryotoxicity assays: the embryonic stem cell test Methods Mol Biol 329 371 395 16846005 1:CAS:528:DC%2BD28XislKhs7Y%3D
64. AE Seiler R Buesen K Hayess K Schlechter A Visan E Genschow B Slawik H Spielmann 2006 Current status of the embryonic stem cell test: the use of recent advances in the field of stem cell technology and gene expression analysis ALTEX 22 346 352
65. D Sesardic T Leung DR Gaines 2003 Role for standards in assays of botulinum toxins: international collaborative study of three preparations of botulinum type A toxin Biologicals 31 265 276 14624797 10.1016/j.biologicals. 2003.08.001 1:CAS:528:DC%2BD3sXptVeks7w%3D (Pubitemid 37414922)
66. H Spielmann U Gerbracht 2001 The use of dogs as second species in regulatory testing of pesticides. Part II: subacute, subchronic and chronic studies in the dog Arch Toxicol 75 1 21 11368059 10.1007/s002040000195 1:CAS:528:DC%2BD3MXhslyitL4%3D (Pubitemid 32247235)
67. H Spielmann I Pohl B Döring M Liebsch F Moldenhauer 1997 The Embryonic stem cell test, an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells In Vitro Mol Toxicol J Basic Appl Res 10 119 127 1:CAS:528:DyaK2sXjtFaitL8%3D
68. H Spielmann A Seiler S Bremer L Hareng T Hartung H Ahr E Faustman U Haas GJ Moffat H Nau P Vanparys A Piersma JR Sintes J Stuart 2006 The practical application of three validated in vitro embryotoxicity tests. The report and recommendations of an ECVAM/ZEBET workshop (ECVAM workshop #57) Altern Lab Anim 34 527 538 17121476 1:CAS:528:DC%2BD28Xht1aks7bE
69. G Stolper M Klausner J Sheasgreen P Hayden 2005 Development of an in vitro blood-brain barrier model for brain disposition screening of pharmaceuticals Toxicologist 84 257
70. US Congress, Office of Technology Assessment (1986) Alternatives to animal use in research, testing, and education (OTA-BA-273). US Government Printing Office, Washington
71. US Department of Agriculture, Animal and Plant Health Inspection Service (2009) Annual report animal usage by fiscal year. US Department of Agriculture. http://www.aphis.usda.gov/animal-welfare/efoia/downloads/2009-Animals-Used-In- Research.pdf
72. van der Jagt K, Munn S, Tørsløv J, de Bruijn J (2004) Alternative approaches can reduce the use of test animals under REACH. http://ecb.jrc.ec.europa.eu/documents/REACH/PUBLICATIONS/Reducing-the-use-of- test-animals-under-REACH-IHCP-report.pdf
73. M Verwei JA van Burgsteden CA Krul JJ van de Sandt AP Freidig 2006 Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling Toxicol Lett 165 79 87 16517103 10.1016/j.toxlet. 2006.01.017 1:CAS:528:DC%2BD28XlvF2nsrg%3D (Pubitemid 43867181)
74. MK Vickaryous BK Hall 2006 Human cell type diversity, evolution, development, and classification with special reference to cells derived from the neural crest Biol Rev Camb Philos Soc 81 425 455 16790079 10.1017/ S1464793106007068 (Pubitemid 44092346)
75. JD Walker I Gerner E Hulzebos K Schlegel 2004 (Q)SARs for predicting skin irritation and corrosion: mechanisms, transparency and applicability of predictions QSAR Comb Sci 23 721 725 10.1002/qsar.200430879 1:CAS:528: DC%2BD2cXhtVKls7nP (Pubitemid 39578074)
76. JD Walker I Gerner E Hulzebos K Schlegel 2005 The skin irritation corrosion rules estimation tool (SICRET) QSAR Comb Sci 24 378 384 10.1002/qsar.200430906 1:CAS:528:DC%2BD2MXktlSltrg%3D (Pubitemid 40637939)
77. S Whitlow H Burgin N Clemann 2007 The embryonic stem cell test for the early selection of pharmaceutical compounds ALTEX 24 3 7 17361315 (Pubitemid 46563939)
78. NI zur Nieden G Kempka HJ Ahr 2004 Molecular multiple endpoint embryonic stem cell test-a possible approach to test for the teratogenic potential of compounds Toxicol Appl Pharmacol 194 257 269 14761682 10.1016/j.taap.2003.09.019 1:CAS:528:DC%2BD2cXptValsg%3D%3D (Pubitemid 38175288)